Qube Research & Technologies (QRT)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.4M Buy
190,717
+113,217
+146% +$14.1M 0.03% 770
2025
Q4
$9.45M Buy
+77,500
New +$8.89M 0.01% 1381
2025
Q3
Sell
-22,595
Closed -$1.87M 4010
2025
Q2
$1.87M Sell
22,595
-88,367
-80% -$7.05M ﹤0.01% 2217
2025
Q1
$9M Buy
+110,962
New +$9.92M 0.01% 1201
2024
Q4
Sell
-7,337
Closed -$711K 3866
2024
Q3
$725K Sell
7,337
-4,733
-39% -$465K ﹤0.01% 2145
2024
Q2
$1.12M Sell
12,070
-73,437
-86% -$6.58M ﹤0.01% 1837
2024
Q1
$8.11M Sell
85,507
-19,837
-19% -$1.84M 0.01% 959
2023
Q4
$9.41M Buy
105,344
+19,837
+23% +$1.47M 0.02% 758
2023
Q3
$6.24M Buy
85,507
+82,238
+2,516% +$6.57M 0.02% 838
2023
Q2
$71.6K Sell
3,269
-7,611
-70% -$636K ﹤0.01% 2009
2023
Q1
$829K Buy
+10,880
New +$903K ﹤0.01% 1364
2022
Q4
Sell
-78,830
Closed -$6.25M 3060
2022
Q3
$6.25M Buy
+78,830
New +$6.65M 0.04% 548
2022
Q2
Sell
-78,087
Closed -$7.02M 3209
2022
Q1
$7.02M Buy
+78,087
New +$7.21M 0.06% 421
2021
Q3
Sell
-146,755
Closed -$19.9M 2846
2021
Q2
$19.9M Buy
+146,755
New +$19.3M 0.23% 91
2021
Q1
Sell
-203,469
Closed -$28.6M 2475
2020
Q4
$28.6M Buy
+203,469
New +$26.1M 0.41% 37
2020
Q3
Sell
-1,357
Closed -$152K 2165
2020
Q2
$152K Sell
1,357
-16,743
-93% -$1.65M ﹤0.01% 1464
2020
Q1
$1.4M Buy
+18,100
New +$1.6M 0.06% 297

Other funds holding XBI

Qube Research & Technologies (QRT)'s XBI Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its State Street SPDR S&P Biotech ETF (XBI) stake by 146% in Q1 2026, buying an estimated $14.1M and bringing the position to 190,717 shares worth $24.4M. The position accounts for 0.03% of the portfolio, ranked #770.

Qube Research & Technologies (QRT) first reported a position in XBI in Q1 2020 and has held it in 17 quarters since. The position peaked at $28.6M in Q4 2020. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Qube Research & Technologies (QRT) held 190,717 shares of State Street SPDR S&P Biotech ETF worth $24.4M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 113,217 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $14.1M.
  • State Street SPDR S&P Biotech ETF made up 0.03% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #770 holding.
  • Qube Research & Technologies (QRT) first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and has held it in 17 quarters since.
  • Qube Research & Technologies (QRT)'s State Street SPDR S&P Biotech ETF position peaked at $28.6M in Q4 2020.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.